D.E. Shaw & Co’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-21,880
| Closed | -$52K | – | 2853 |
|
|
2019
Q2 | $52K | Sell |
21,880
-1,979
| -8% | -$4.7K | ﹤0.01% | 2523 |
|
|
2019
Q1 | $89K | Sell |
23,859
-2,900
| -11% | -$10.8K | ﹤0.01% | 2454 |
|
|
2018
Q4 | $96K | Sell |
26,759
-199,251
| -88% | -$715K | ﹤0.01% | 2463 |
|
|
2018
Q3 | $1.3M | Buy |
226,010
+172,248
| +320% | +$988K | ﹤0.01% | 1723 |
|
|
2018
Q2 | $269K | Buy |
53,762
+7,336
| +16% | +$36.7K | ﹤0.01% | 2355 |
|
|
2018
Q1 | $238K | Buy |
46,426
+9,232
| +25% | +$47.3K | ﹤0.01% | 2317 |
|
|
2017
Q4 | $224K | Buy |
+37,194
| New | +$224K | ﹤0.01% | 2363 |
|
|
2017
Q3 | – | Sell |
-16,327
| Closed | -$76K | – | 2682 |
|
|
2017
Q2 | $76K | Sell |
16,327
-50,046
| -75% | -$233K | ﹤0.01% | 2339 |
|
|
2017
Q1 | $329K | Buy |
66,373
+23,327
| +54% | +$116K | ﹤0.01% | 2128 |
|
|
2016
Q4 | $478K | Buy |
43,046
+22,688
| +111% | +$252K | ﹤0.01% | 2046 |
|
|
2016
Q3 | $189K | Sell |
20,358
-32,043
| -61% | -$297K | ﹤0.01% | 2341 |
|
|
2016
Q2 | $333K | Sell |
52,401
-7,893
| -13% | -$50.2K | ﹤0.01% | 2212 |
|
|
2016
Q1 | $393K | Buy |
60,294
+5,906
| +11% | +$38.5K | ﹤0.01% | 2152 |
|
|
2015
Q4 | $441K | Buy |
54,388
+33,103
| +156% | +$268K | ﹤0.01% | 2120 |
|
|
2015
Q3 | $156K | Sell |
21,285
-20,754
| -49% | -$152K | ﹤0.01% | 2401 |
|
|
2015
Q2 | $431K | Buy |
+42,039
| New | +$431K | ﹤0.01% | 2214 |
|